Managing Director Kiran Mazumdar Shaw

Jump to

Biocon Q4 net up 25%, divests stake in German unit

India's largest listed biotechnology firm Biocon said on Thursday it would divest its stake in German unit AxiCorp, after roughly meeting estimates with a 25% rise in the fourth-quarter net profit.
Biocon: Oral insulin fails to meet primary target

Biocon on Tuesday said initial data from late-stage clinical trials on its experimental oral insulin drug for diabetes did not meet the desired results, but said it was committed to the global development of the drug.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Managing Director Kiran Mazumdar Shaw

Biocon Q4 net up 25%, divests stake in German unit

Biocon: Oral insulin fails to meet primary target